Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02834403
Title L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients
Recruitment Recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Polly A. Niravath, MD
Indications

triple-receptor negative breast cancer

Therapies

Pegfilgrastim

Docetaxel + L-NMMA

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.